Genes and immune cells predict immunotherapy success in bladder cancer
Sets of genes associated with resistance to immunotherapy in patients with metastatic urothelial cancer of…
Browsing: Bladder Cancer
Shorter radiotherapy course reduces risk of bladder cancer returning
Giving people with bladder cancer fewer but larger doses of radiation reduces the risk of…
Bladder cancer – When to use chemotherapy
In patients with bladder cancer, chemotherapy effectiveness is partially determined by the body’s immune system…
Multiple sclerosis may not put you at risk for breast, colorectal cancers
People with multiple sclerosis (MS) may not be at higher risk of developing two of…
Gemcitabine and daily radiotherapy for bladder preservation in muscle-invasive bladder cancer
Bladder preservation with trimodality therapy can be a safe and effective alternative to cystectomy for…
Neo-adjuvant immunotherapy combination effective for non-metastatic bladder cancer
In the scientific journal Nature Medicine, researchers at the Netherlands show that neoadjuvant immunotherapy using a…
Dual checkpoint blockade promising as pre-surgical approach for certain patients with localised bladder cancer
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1)…
Urine-based liquid biopsy test outperforms urine cytology in detecting bladder cancer
Analysis of DNA copy number variants (CNVs) in the cells exfoliated in urine showed better…
Immunotherapy improves survival in advanced bladder cancer patients
Immunotherapy drug avelumab has been shown to significantly improve survival in patients with the most…
International team identifies a new regulatory pathway in bladder cancer
Researchers from Johns Hopkins University, USA, in collaboration with Insilico Medicine announce the publication of…